SINEUP Trademark

Trademark Overview


On Friday, January 22, 2021, a trademark application was filed for SINEUP with the United States Patent and Trademark Office. The USPTO has given the SINEUP trademark a serial number of 79307287. The federal status of this trademark filing is REGISTERED as of Tuesday, January 31, 2023. This trademark is owned by Transine Therapeutics Limited. The SINEUP trademark is filed in the Chemical Products and Pharmaceutical Products categories with the following description:

Pharmaceutical preparations for the treatment and prevention of ophthalmological conditions, hearing loss, hematologic diseases, immune response disorders, neurological disorders, respiratory diseases, fibrosis, hepatic diseases, renal diseases, diseases of the pancreas, metabolic diseases, genetic conditions, cancer, infectious diseases and cardiovascular diseases; medical and veterinary preparations for therapeutic purposes for the treatment and prevention of ophthalmological conditions, hearing loss, hematologic diseases, immune response disorders, neurological disorders, respiratory diseases, fibrosis, hepatic diseases, renal diseases, diseases of the pancreas, metabolic diseases, genetic conditions, cancer, infectious diseases and cardiovascular diseases; biological, chemical and biochemical reagents, namely, DNA and RNA sequences and gene editing enzymes, all for medical use; DNA and RNA products for medical use, namely, nucleic acid sequences for medical purposes; therapeutic DN...

chemical preparations for scientific purposes, other than for medical or veterinary use; chemicals for research use, namely, nucleic acid sequences for laboratory or research use; enzymes for research use; DNA and RNA for research use, namely, nucleic acid sequences for laboratory use, nucleic acid sequences for other than medical and veterinary purposes; chemicals for use in the preparation and creation of DNA and RNA, reagents for scientific purposes, other than for medical or veterinary use; enzymes for use in the preparation and creation of DNA and RNA, namely, enzymes for scientific and research purposes; molecular biology research tools in the nature of biological, chemical and biochemical reagents for research use
sineup

General Information


Serial Number79307287
Word MarkSINEUP
Filing DateFriday, January 22, 2021
Status700 - REGISTERED
Status DateTuesday, January 31, 2023
Registration Number6965967
Registration DateTuesday, January 31, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 15, 2022

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment and prevention of ophthalmological conditions, hearing loss, hematologic diseases, immune response disorders, neurological disorders, respiratory diseases, fibrosis, hepatic diseases, renal diseases, diseases of the pancreas, metabolic diseases, genetic conditions, cancer, infectious diseases and cardiovascular diseases; medical and veterinary preparations for therapeutic purposes for the treatment and prevention of ophthalmological conditions, hearing loss, hematologic diseases, immune response disorders, neurological disorders, respiratory diseases, fibrosis, hepatic diseases, renal diseases, diseases of the pancreas, metabolic diseases, genetic conditions, cancer, infectious diseases and cardiovascular diseases; biological, chemical and biochemical reagents, namely, DNA and RNA sequences and gene editing enzymes, all for medical use; DNA and RNA products for medical use, namely, nucleic acid sequences for medical purposes; therapeutic DNA and RNA, namely, nucleic acid sequences for medical purposes
Pseudo MarkSINE UP; SIGNUP
Goods and Serviceschemical preparations for scientific purposes, other than for medical or veterinary use; chemicals for research use, namely, nucleic acid sequences for laboratory or research use; enzymes for research use; DNA and RNA for research use, namely, nucleic acid sequences for laboratory use, nucleic acid sequences for other than medical and veterinary purposes; chemicals for use in the preparation and creation of DNA and RNA, reagents for scientific purposes, other than for medical or veterinary use; enzymes for use in the preparation and creation of DNA and RNA, namely, enzymes for scientific and research purposes; molecular biology research tools in the nature of biological, chemical and biochemical reagents for research use

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateMonday, March 29, 2021
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, March 29, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameHarness Therapeutics Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressGB

Party NameTransine Therapeutics Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressGB

Party NameTransine Therapeutics Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressGB

Trademark Events


Event DateEvent Description
Saturday, March 2, 2024CHANGE OF NAME/ADDRESS REC'D FROM IB
Tuesday, May 30, 2023FINAL DECISION TRANSACTION PROCESSED BY IB
Thursday, May 4, 2023FINAL DISPOSITION NOTICE SENT TO IB
Thursday, May 4, 2023FINAL DISPOSITION PROCESSED
Sunday, April 30, 2023FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, January 31, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, January 31, 2023REGISTERED-PRINCIPAL REGISTER
Tuesday, November 15, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 15, 2022PUBLISHED FOR OPPOSITION
Monday, November 14, 2022NOTIFICATION PROCESSED BY IB
Wednesday, October 26, 2022NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, October 26, 2022NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, October 26, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, October 13, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, September 20, 2022NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Wednesday, September 7, 2022ASSIGNED TO EXAMINER
Wednesday, August 31, 2022NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, August 31, 2022NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Monday, August 22, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Saturday, August 20, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, August 20, 2022TEAS REQUEST FOR RECONSIDERATION RECEIVED
Friday, July 15, 2022ASSIGNED TO EXAMINER
Thursday, April 14, 2022NOTIFICATION OF FINAL REFUSAL EMAILED
Thursday, April 14, 2022FINAL REFUSAL E-MAILED
Thursday, April 14, 2022FINAL REFUSAL WRITTEN
Monday, March 14, 2022ASSIGNED TO EXAMINER
Friday, February 25, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, February 25, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, February 25, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, September 11, 2021REFUSAL PROCESSED BY IB
Wednesday, August 25, 2021NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Wednesday, August 25, 2021REFUSAL PROCESSED BY MPU
Thursday, August 12, 2021NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, August 11, 2021NON-FINAL ACTION WRITTEN
Monday, August 9, 2021ASSIGNED TO EXAMINER
Friday, April 2, 2021APPLICATION FILING RECEIPT MAILED
Monday, March 29, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, March 25, 2021SN ASSIGNED FOR SECT 66A APPL FROM IB